These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
439 related articles for article (PubMed ID: 18386299)
1. Is the mu-oxo-mu-peroxodiiron intermediate of a ribonucleotide reductase biomimetic a possible oxidant of epoxidation reactions? de Visser SP Chemistry; 2008; 14(15):4533-41. PubMed ID: 18386299 [TBL] [Abstract][Full Text] [Related]
2. Structural characterization of the peroxodiiron(III) intermediate generated during oxygen activation by the W48A/D84E variant of ribonucleotide reductase protein R2 from Escherichia coli. Baldwin J; Krebs C; Saleh L; Stelling M; Huynh BH; Bollinger JM; Riggs-Gelasco P Biochemistry; 2003 Nov; 42(45):13269-79. PubMed ID: 14609338 [TBL] [Abstract][Full Text] [Related]
3. The effect and influence of cis-ligands on the electronic and oxidizing properties of nonheme oxoiron biomimetics. A density functional study. de Visser SP; Nam W J Phys Chem A; 2008 Dec; 112(50):12887-95. PubMed ID: 18616332 [TBL] [Abstract][Full Text] [Related]
4. Tetranuclear iron(III) complexes of an octadentate pyridine-carboxylate ligand and their catalytic activity in alkane oxidation by hydrogen peroxide. Gutkina EA; Trukhan VM; Pierpont CG; Mkoyan S; Strelets VV; Nordlander E; Shteinman AA Dalton Trans; 2006 Jan; (3):492-501. PubMed ID: 16395449 [TBL] [Abstract][Full Text] [Related]
5. Propene activation by the oxo-iron active species of taurine/alpha-ketoglutarate dioxygenase (TauD) enzyme. How does the catalysis compare to heme-enzymes? de Visser SP J Am Chem Soc; 2006 Aug; 128(30):9813-24. PubMed ID: 16866538 [TBL] [Abstract][Full Text] [Related]
6. What factors influence the ratio of C-H hydroxylation versus C=C epoxidation by a nonheme cytochrome P450 biomimetic? de Visser SP J Am Chem Soc; 2006 Dec; 128(49):15809-18. PubMed ID: 17147391 [TBL] [Abstract][Full Text] [Related]
7. Use of a chemical trigger for electron transfer to characterize a precursor to cluster X in assembly of the iron-radical cofactor of Escherichia coli ribonucleotide reductase. Saleh L; Krebs C; Ley BA; Naik S; Huynh BH; Bollinger JM Biochemistry; 2004 May; 43(20):5953-64. PubMed ID: 15147179 [TBL] [Abstract][Full Text] [Related]
8. Is the ruthenium analogue of compound I of cytochrome p450 an efficient oxidant? A theoretical investigation of the methane hydroxylation reaction. Sharma PK; De Visser SP; Ogliaro F; Shaik S J Am Chem Soc; 2003 Feb; 125(8):2291-300. PubMed ID: 12590559 [TBL] [Abstract][Full Text] [Related]
9. Structural and spectroscopic characterization of (mu-hydroxo or mu-oxo)(mu-peroxo)diiron(III) complexes: models for peroxo intermediates of non-heme diiron proteins. Zhang X; Furutachi H; Fujinami S; Nagatomo S; Maeda Y; Watanabe Y; Kitagawa T; Suzuki M J Am Chem Soc; 2005 Jan; 127(3):826-7. PubMed ID: 15656607 [TBL] [Abstract][Full Text] [Related]
10. Metal-peroxo versus metal-oxo oxidants in non-heme iron-catalyzed olefin oxidations: computational and experimental studies on the effect of water. Quiñonero D; Morokuma K; Musaev DG; Mas-Ballesté R; Que L J Am Chem Soc; 2005 May; 127(18):6548-9. PubMed ID: 15869272 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, structure, and catalytic activity of mononuclear iron and (mu-Oxo)diiron complexes with the ligand 2,6-bis(N-methylbenzimidazol-2-yl)pyridine. Wang X; Wang S; Li L; Sundberg EB; Gacho GP Inorg Chem; 2003 Dec; 42(24):7799-808. PubMed ID: 14632495 [TBL] [Abstract][Full Text] [Related]
12. Peroxo-type intermediates in class I ribonucleotide reductase and related binuclear non-heme iron enzymes. Jensen KP; Bell CB; Clay MD; Solomon EI J Am Chem Soc; 2009 Sep; 131(34):12155-71. PubMed ID: 19663382 [TBL] [Abstract][Full Text] [Related]
13. Epoxidation and 1,2-dihydroxylation of alkenes by a nonheme iron model system - DFT supports the mechanism proposed by experiment. Comba P; Rajaraman G Inorg Chem; 2008 Jan; 47(1):78-93. PubMed ID: 18072762 [TBL] [Abstract][Full Text] [Related]
14. Biomimetic iron-catalyzed asymmetric epoxidation of aromatic alkenes by using hydrogen peroxide. Gelalcha FG; Anilkumar G; Tse MK; Brückner A; Beller M Chemistry; 2008; 14(25):7687-98. PubMed ID: 18567024 [TBL] [Abstract][Full Text] [Related]
15. How does the axial ligand of cytochrome P450 biomimetics influence the regioselectivity of aliphatic versus aromatic hydroxylation? de Visser SP; Tahsini L; Nam W Chemistry; 2009; 15(22):5577-87. PubMed ID: 19347895 [TBL] [Abstract][Full Text] [Related]
16. Density functional study of a micro-1,1-carboxylate bridged Fe(III)-O-Fe(IV) model complex. 2. Comparison with ribonucleotide reductase intermediate X. Han WG; Lovell T; Liu T; Noodleman L Inorg Chem; 2004 Jan; 43(2):613-21. PubMed ID: 14731023 [TBL] [Abstract][Full Text] [Related]
17. Functional models of nonheme diiron enzymes: reactivity of the μ-oxo-μ-1,2-peroxo-diiron(iii) intermediate in electrophilic and nucleophilic reactions. Kripli B; Szávuly M; Csendes FV; Kaizer J Dalton Trans; 2020 Feb; 49(6):1742-1746. PubMed ID: 31967142 [TBL] [Abstract][Full Text] [Related]
18. A density functional evaluation of an Fe(III)-Fe(IV) model diiron cluster: comparisons with ribonucleotide reductase intermediate X. Han WG; Lovell T; Liu T; Noodleman L Inorg Chem; 2003 Apr; 42(8):2751-8. PubMed ID: 12691585 [TBL] [Abstract][Full Text] [Related]
19. Reactivity of molecular dioxygen towards a series of isostructural dichloroiron(III) complexes with tripodal tetraamine ligands: general access to mu-oxodiiron(III) complexes and effect of alpha-fluorination on the reaction kinetics. Thallaj NK; Rotthaus O; Benhamou L; Humbert N; Elhabiri M; Lachkar M; Welter R; Albrecht-Gary AM; Mandon D Chemistry; 2008; 14(22):6742-53. PubMed ID: 18561351 [TBL] [Abstract][Full Text] [Related]
20. (Mu-1,2-peroxo)diiron(III/III) complex as a precursor to the diiron(III/IV) intermediate X in the assembly of the iron-radical cofactor of ribonucleotide reductase from mouse. Yun D; García-Serres R; Chicalese BM; An YH; Huynh BH; Bollinger JM Biochemistry; 2007 Feb; 46(7):1925-32. PubMed ID: 17256972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]